Industry, equipment vendors, and regulators are busy refining the precision and reliability of dissolution testing. Solid dosage formulators rely on dissolution testing to mechanically model the ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE:A) today introduced the 708-DS Dissolution Apparatus, a quality control instrument that can be configured for manual and ...

US Pharmacopeia apparatuses for testing the dissolution of transdermal drugs produce good, reproducible results. Yet some scientists believe that further modifications could improve the instruments?

Pharmaceutical testing is a must to ensure that all medications meet the top quality, safety, and performance requirements before they enter the market. CD Formulation’s cGMP-compliant laboratory is ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Dissolution Testing in Pharma - From Development to Regulatory Approval" training has been added to ResearchAndMarkets.com's offering. Dissolution ...

Dissolution and drug release tests are directly relevant to the safety and efficacy of many common pharmaceutical dosage forms. To achieve reliable and reproducible results, it is important that ...

A fully automated dissolution lab is an integrated, end to end architecture that enables reproducible testing, continuous ...

Agilent Technologies Inc. has introduced the 280-DS Mechanical Qualification System, a new instrument for routine and effortless calibration of a dissolution apparatus. The 280-DS accurately measures, ...

The Pharmaceutical Dissolution Testing Services Market is poised for significant growth, with a projected market value of US$1.53 billion by 2033. This surge represents a substantial increase from the ...

NEWARK, Del, Dec. 13, 2022 (GLOBE NEWSWIRE) -- During the forecast period 2023-2033, the pharmaceutical dissolution testing services market is expected to grow at a value of 8.3% CAGR, according to ...